Home LiteratureArticle Details
PMID: 12507778 Published · ppublish English Journal Article Research Support, U.S. Gov't, Non-P.H.S. Research Support, U.S. Gov't, P.H.S.

Selective increase in TNF alpha permeation across the blood-spinal cord barrier after SCI.

Journal of neuroimmunology ·Vol. 134 ·No. 1-2 ·2003-01-00 ·Pages 111-7

Pan W, Zhang L, Liao J, Csernus B, Kastin AJ

Abstract

We generated a novel mouse model of spinal cord injury (SCI) by hemisection of the right L1 lumbar spinal cord, measured the permeability of the blood-spinal cord barrier (BSCB), and tested the hypothesis that tumor necrosis factor alpha (TNF alpha) penetrates the injured BSCB by an enhanced transport system. SCI produced stereotypical sensorimotor deficits resembling the classically described Brown-Seqúard syndrome. Disruption of the BSCB was reflected by increased spinal cord uptake of radiolabeled albumin from blood; this was transient (immediately after SCI) and confined to the lumbar spinal cord. By contrast, specific increase in the entry of TNF alpha was detected in brain, cervical, thoracic, and lumbar spinal cord at 1 week after SCI, in addition to its immediate and transient increase consistent with barrier disruption. Lack of a second peak of increase in the entry of IL1 beta further supported the specificity of the TNF alpha response. Moreover, enhanced uptake of radiolabeled TNF alpha was suppressed by excess non-radiolabeled TNF alpha, indicating competition of entry via the known transport system for TNF alpha. Therefore, upregulation of the transport system after SCI probably mediates the increased permeation of TNF alpha across the BSCB. Enhanced entry of TNF alpha at 1 week after SCI was concurrent with sensorimotor and gait improvement of the mouse. We conclude that SCI by lumbar hemisection activates the transport system for TNF alpha at the BBB and suggest that selective permeation of TNF alpha may facilitate functional recovery.

MeSH Terms
Albumins/pharmacokinetics Animals Blood-Brain Barrier/immunology Disease Models, Animal Interleukin-1/immunology,metabolism,pharmacokinetics Lumbar Vertebrae Male Mice Mice, Inbred ICR Nerve Regeneration/immunology Protein Transport/immunology Recovery of Function/immunology Spinal Cord/immunology,metabolism,physiopathology Spinal Cord Injuries/blood,immunology,physiopathology Tumor Necrosis Factor-alpha/immunology,metabolism,pharmacokinetics Up-Regulation/immunology
Chemicals
Albumins Interleukin-1 Tumor Necrosis Factor-alpha
Authors & Affiliations
5 authors, click to expand affiliations / ORCID
Pan Weihong
Department of Medicine and Neuroscience Program, Tulane University School of Medicine and VA Medical Center, New Orleans, LA 70112-1262, USA. wpan@tulane.edu
Zhang Lihua
Liao Jie
Csernus Balazs
Kastin Abba J
Article Info
Journal
Journal of neuroimmunology
Abbr.
J Neuroimmunol
ISSN
0165-5728
Published
2003-01-00
Pages
111-7
Language
English
Region
Netherlands
NLM ID
8109498
Subset
IM
Grants
NIAAA NIH HHS · AA12865 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com